International

Latest international events, highlights, advancements and treatments on mesothelioma. Stay one step ahead of the disease. Get informed.

Asia | Biomarkers | Diagnosis | Immune Systems | Immunotherapy | International | Prognosis | Research | Treatments

These Proteins Appear to Shorten Mesothelioma Survival
ByAlex Strauss August 17, 2017

New evidence suggests that mesothelioma patients whose tumors express two particular proteins do not live as long as other mesothelioma…

Read More These Proteins Appear to Shorten Mesothelioma Survival
Asia | Biopsy | Diagnosis | International

Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients
ByAlex Strauss August 14, 2017

Pleural mesothelioma patients who are recommended for medical thoracoscopy can rest assured that the procedure is “a valuable and safe”…

Read More Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients
Chemotherapy | Europe | International | New Studies | Research | Treatments

Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival
ByAlex Strauss August 12, 2017

German surgeons are reporting on a potential new way to improve outcomes for people with malignant pleural mesothelioma by infusing…

Read More Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival
Asbestos | Canada | Compensation | International | Occupations | Statistics

The Economic Burden of Malignant Mesothelioma
ByAlex Strauss August 9, 2017

Patients with malignant mesothelioma and their families are not the only ones impacted by the costs associated with the asbestos-linked…

Read More The Economic Burden of Malignant Mesothelioma
Asbestos | Europe | International | Statistics

Malignant Mesothelioma Risk May Eventually Plateau
ByAlex Strauss August 5, 2017August 5, 2017

The risk for developing malignant pleural mesothelioma after asbestos exposure may not increase indefinitely. Researchers in Italy say the chances…

Read More Malignant Mesothelioma Risk May Eventually Plateau
Europe | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments

Long-Term Peritoneal Mesothelioma Survival with Apitolisib
ByAlex Strauss August 2, 2017

There is hopeful news this week about the survivability of peritoneal mesothelioma, particularly when relapses are treated with a powerful…

Read More Long-Term Peritoneal Mesothelioma Survival with Apitolisib
Immune Systems | Immunotherapy | International | New Drugs | New Studies | Research | Treatments

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
ByAlex Strauss July 23, 2017

A large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant mesothelioma…

Read More Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
Australia | Mesothelioma | New Studies | Radiation Therapy | Research | Statistics | Treatments

High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms
ByAlex Strauss July 21, 2017

High dose radiotherapy may work wonders for some kinds of cancer but it is not recommended as a way to manage…

Read More High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms
Chemotherapy | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments

Study to Test New Three-Drug Treatment for Pleural Mesothelioma
ByAlex Strauss July 14, 2017July 14, 2017

The makers of a VEGF-inhibitor called nintedanib are recruiting patients with unresectable pleural mesothelioma for a Phase III clinical trial…

Read More Study to Test New Three-Drug Treatment for Pleural Mesothelioma
Asbestos | Diagnosis | Europe | Genetics | International | Research | Statistics

BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk
ByAlex Strauss July 9, 2017

The question of why some asbestos-exposed people develop malignant mesothelioma and others do not has been a key focus of…

Read More BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk

1 (888) 378-1331

International

These Proteins Appear to Shorten Mesothelioma Survival

Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients

Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival

The Economic Burden of Malignant Mesothelioma

Malignant Mesothelioma Risk May Eventually Plateau

Long-Term Peritoneal Mesothelioma Survival with Apitolisib

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms

Study to Test New Three-Drug Treatment for Pleural Mesothelioma

BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES